Author
Listed:
- Umme Thayyiba Khatoon
(Department of Business Administration, Jazan University, Jazan 45142, Saudi Arabia)
- Aditya Velidandi
(Department of Biotechnology, National Institute of Technology, Warangal 506004, Telangana, India)
Abstract
Nanoparticle technology has emerged as a fundamental component across various industries, including electronics, renewable energy, textiles, and medical biotechnology, particularly for targeted drug delivery applications. Commercialization has profoundly impacted economic growth, especially in the pharmaceutical and electronics industries. Moreover, it has improved workforce education and training, generating millions of employment prospects associated with nanotechnology development. By 2024, the Organisation for Economic Co-operation and Development anticipates that the global market for nanotechnology products will attain a value of United States Dollar (USD) 1 trillion to USD 3 trillion, resulting in the creation of over 2 million new employments globally. The swift progression of nanoparticle technology from 2000 to 2024 is primarily propelled by substantial industrial investment in research and development, alongside collaborations with academic institutions. The National Nanotechnology Initiative in the United States (US) has significantly contributed to these developments, with federal funding exceeding USD 30 billion by 2024 since its establishment in 2001. This funding has catalyzed significant advancements in both commercial and research applications of nanotechnology. Patent data highlights this expansion, with China establishing itself as the preeminent nation in nanotechnology patents. From 2000 to 2024, China steadily raised its proportion of nanotechnology patents, accounting for almost 40% of the global total by 2024. The US, Japan, Germany, and the Republic of Korea continued to be significant contributors, together advancing the frontiers of innovation in nanotechnology. In this timeframe, the quantity of nanotechnology-related patents increased by more than 150%, demonstrating the swift growth of the sector. The regulation of nanotechnology in the US is primarily managed by the Food and Drug Administration, particularly about healthcare and biotechnology applications. As the scope of nanotechnology uses has expanded, there is an increasing demand for more extensive regulations concerning potential long-term environmental and health effects. The future trajectory of nanotechnology, both in the US and worldwide, will hinge on continuous invention, economic advancement, and the progression of governmental policy. By upholding a robust regulatory framework and promoting ongoing collaboration between academics and industry, the complete potential of nanotechnology in advancing industrial and societal progress can be actualized.
Suggested Citation
Umme Thayyiba Khatoon & Aditya Velidandi, 2025.
"An Overview on the Role of Government Initiatives in Nanotechnology Innovation for Sustainable Economic Development and Research Progress,"
Sustainability, MDPI, vol. 17(3), pages 1-37, February.
Handle:
RePEc:gam:jsusta:v:17:y:2025:i:3:p:1250-:d:1583411
Download full text from publisher
References listed on IDEAS
- Oliver Gassmann & Martin A. Bader & Mark James Thompson, 2021.
"Fundamentals of Intellectual Property Rights,"
Management for Professionals, in: Patent Management, edition 1, chapter 1, pages 1-25,
Springer.
- Mohammed Abdulfasi, 2024.
"The Transformative Patent Landscape in Saudi Arabia Since the Saudi Vision 2030 Announcement,"
Publications, MDPI, vol. 12(4), pages 1-16, December.
Full references (including those not matched with items on IDEAS)
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jsusta:v:17:y:2025:i:3:p:1250-:d:1583411. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.